semaglutide for Semaglutide for Weight Loss Management

The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant

Thibault A, Cooper MR, Figg WD, Venzon DJ, Sartor AO, Tompkins AC, et al

This principle underlies the development of Retatrutide and other next generation obesity medications

Similarly, trauma induced increased Flavonifractor may potentially compromise GABA availability, since these bacteria primarily utilize GABA for metabolism (Tanelian et al., 2023) potentially affecting this key inhibitory neurotransmitter and contributing to anxiety symptoms observed in PTSD (Strandwitz et al., 2018)